Abstract
The common opportunistic parasites which cause morbidity and/or death in immunocompromisedpopulations are predominantly gastrointestinal ones. This study explained the molecular and parasitologicalaspects on selected opportunistic intestinal parasites in selected groups of immune compromised patientsfrom Al-Anbar hospitals and private laboratories.In the current study, were taken (130) stool samples from immune compromised patients divided into threegroups (50) chemotherapy recipient, (40) chronic renal failures, (40) diabetic Mellitus, and (30) samplesapparently healthy as control. A questionnaire was filled out on each subject including all personal andmedical history. Stool samples were collected from all groups for detection of the parasites.The results were displayed the ratio of opportunistic parasites in (55.3)% of patients, and healthy controlwas (3.3)%. The results showed that the highest group had parasites in those with chemotherapy (64)%,chronic renal failure (57.5)%, and diabetic (42.5)% individually. The highest rate of infection appeared withBlastocystis hominins(26.1%), Cryptosporidium(22.3%), and Cyclospora cayetanensis (8.4%). The age ofthe patient was ranged between 4-66 years, the Mean was 47.5 and deviation was± 9.12, also, the weightof the patient was ranging between 14-85, the mean was 70.3 and deviation ± 8.07. Three cases of mixedinfection were detected.
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Indian Journal of Forensic Medicine & Toxicology
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
